Next-Generation Sequencing (NGS) in Clinical Mycology-Introduction, Application, and Keynote

Introduction

Next-generation sequencing (NGS) in Clinical Mycology is revolutionizing the diagnosis, typing, and antifungal resistance profiling of fungal pathogens.

Application

Here’s an overview of its applications:

1. Pathogen Identification-NGS can identify fungal species with high precision, including rare and emerging pathogens that are difficult to detect using conventional methods.

• Whole Genome Sequencing (WGS): Identifies fungal species based on entire genomes.
• Targeted Sequencing (e.g., ITS, 18S rRNA): Amplifies specific fungal genomic regions for species-level identification.
• Metagenomics: Enables detection of fungi in mixed microbial communities directly from clinical specimens without culture.

2. Antifungal Resistance Detection-NGS can identify genetic mutations associated with resistance to antifungal drugs, such as:

Candida spp.:

• CDR1, CDR2: Efflux pumps contribute to azole resistance.
• ERG11: Azole resistance due to mutations in ergosterol synthesis.
• FKS1, FKS2: Echinocandin resistance (glucan synthase mutations).

Aspergillus spp.: CYP51A: Azole resistance due to mutations in ergosterol synthesis.

3. Epidemiological Studies and Outbreak Investigations-NGS is instrumental in understanding the spread of fungal infections within healthcare settings by:

• Comparing genomic sequences of fungal isolates to identify sources of infection.
• Tracking the evolution of multidrug-resistant fungal strains.

4. Study of Host-Fungal Interactions-Transcriptomic and metatranscriptomic studies (RNA sequencing) provide insights into:

• Host immune responses to fungal infections.
• Mechanisms by which fungi evade immune defenses.

5. Fungal Microbiome Analysis-NGS facilitates the study of the fungal microbiota (mycobiome) in various clinical conditions, such as:

• Pulmonary aspergillosis.
• Gastrointestinal and systemic fungal infections.
• Dermatological conditions caused by dermatophytes.

6. Detection of Polymicrobial Infections-NGS can detect co-infections involving fungi and bacteria or viruses in complex clinical specimens, guiding more effective treatment strategies.
7. The Discovery of New Fungal Species- NGS enables the discovery and characterization of novel fungal species, improving our understanding of fungal biodiversity and its clinical relevance.
8. Functional Genomics and Proteomics-NGS supports functional studies of fungal genes and proteins, which can lead to:

• Identification of virulence factors.
• Discovery of novel therapeutic targets.
  

Advantages of NGS in Clinical Mycology

• Culture-independent identification.
• High sensitivity for detecting low fungal loads.
• Simultaneous detection of multiple fungal species.
• Comprehensive profiling of antifungal resistance.

Challenges

• High costs and technical expertise required.
• Interpretation of results requires bioinformatics tools and databases.
• Limited standardization for clinical application.

Keynote

NGS has immense potential to advance clinical mycology by improving diagnostic accuracy, understanding antifungal resistance, and guiding personalized treatment approaches for fungal infections.